tiprankstipranks
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market

Compare Simcere Pharmaceutical Group Limited (2096) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Simcere Pharmaceutical Group Limited
HK$13.74
HK$35.66B
20.38
69.30%
3 Buy
0 Hold
0 Sell
Strong Buy
InnoCare Pharma Ltd.
HK$11.75
HK$22.49B
31.11
77.91%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$26.46
HK$39.86B
-18.01
87.93%
1 Buy
1 Hold
0 Sell
Moderate Buy
Everest Medicines Ltd.
HK$51.50
HK$13.47B
-38.53
-22.98%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$83.35
HK$45.30B
34.57
191.08%
6 Buy
0 Hold
0 Sell
Strong Buy
Ascentage Pharma Group International
HK$50.90
HK$18.20B
-13.81
32.47%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2096
Simcere Pharmaceutical Group Limited
13.73
5.69
70.77%
HK:9969
InnoCare Pharma Ltd.
14.98
6.34
73.38%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
26.46
11.28
74.31%
HK:1952
Everest Medicines Ltd.
37.28
-12.97
-25.81%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
83.25
52.90
174.30%
HK:6855
Ascentage Pharma Group International
49.08
10.58
27.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts